Why is Thyrocare Tech. falling/rising?

As of 28-Aug, Thyrocare Technologies Ltd is experiencing a price increase, currently at 1,279.70, reflecting a rise of 11.8 points or 0.93%. Today's performance summary indicates that the stock has outperformed its sector by 1.72% and has been on a gaining streak for the last three days, accumulating a total return of 1.37%. Despite opening with a significant loss of 6.07%, the stock reached an intraday high of Rs 1300.15. Over the past week, the stock has seen a decline of 4.58%, but it has performed positively over the last month with a return of 3.01%. The company has demonstrated strong financial health, with a high return on equity (ROE) of 20.45% and a low debt-to-equity ratio, alongside impressive net profit growth of 56.61% in its latest quarterly results. However, the stock's valuation appears high compared to its peers, and 100% of promoter shares are pledged, which could pose risks in a declining market.
Broader market context shows that while Thyrocare Technologies has outperformed the Sensex in the long term, with a 46.66% return over the past year compared to the index's decline of 2.08%, it has faced challenges in the short term. The stock's recent performance has been volatile, opening lower and touching a significant intraday low, yet it has managed to recover and gain ground. In the context of the broader market, the Sensex has also seen a decline of 2.34% over the past week, indicating that the stock's recent upward movement is somewhat counter to the overall market trend, suggesting investor confidence despite broader market pressures.